ClinConnect ClinConnect Logo
Search / Trial NCT02878967

Standardized Long Term Follow-up of Patients After Endovascular Embolization of a Brain Aneurysm

Launched by FONDATION OPHTALMOLOGIQUE ADOLPHE DE ROTHSCHILD · Aug 22, 2016

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is focused on understanding the long-term effects of a treatment called endovascular embolization for patients with brain aneurysms. An aneurysm is a weak spot in a blood vessel in the brain that can bulge and potentially cause serious health issues. The researchers want to gather consistent information over time about how these patients are doing after their treatment, specifically looking to see if the aneurysm comes back or if they need more procedures in the future.

To participate in this study, you need to be at least 18 years old and have undergone successful embolization for a brain aneurysm. There are no specific exclusions, so if you meet these criteria, you may be eligible. If you join the trial, you can expect to provide follow-up information about your health over time. This study is currently recruiting participants, and your involvement could help improve care and understanding for future patients with brain aneurysms.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • curative embolization of a brain aneurysm
  • age \>18 years old
  • Exclusion Criteria:
  • none

About Fondation Ophtalmologique Adolphe De Rothschild

The Fondation Ophtalmologique Adolphe de Rothschild is a leading French institution dedicated to advancing ophthalmic research and patient care. Renowned for its commitment to innovation in eye health, the foundation conducts cutting-edge clinical trials aimed at improving treatments for various ocular conditions. With a multidisciplinary team of experts, the foundation collaborates with academic and industry partners to enhance understanding of eye diseases and develop novel therapeutic solutions, ultimately striving to improve patient outcomes and quality of life in ophthalmology.

Locations

Paris, , France

Patients applied

0 patients applied

Trial Officials

Raphaël Blanc, MD

Principal Investigator

Fondation Ophtalmologique Adolphe de Rothschild

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials